Improving Cotton Plant Quality Using CRISPR/Cas Technology (ASTER TEKSTİL COTTON PROJECT)
Ongoing
Principal Investigator:
Project Acceptance Date:
01.08.2023
Project Duration:
24 Months
Funding Program:
Private Sector – ASTER TEKSTİL
Our university brings together academic knowledge and industry needs to develop collaborations in various fields. Through joint efforts established between researchers and the private sector, project ideas are brought to life with appropriate grant and fund support. This section provides general information on the work carried out within the scope of university–industry collaborations, and you can find the university–industry collaborations carried out within this scope below.
Assessment of Electromagnetic Fields Emitted by Wind Power Plants into the Environment According to National and International Limits
Completed
Principal Investigator:
Project Acceptance Date:
24.01.2025
Project Duration:
12 Months
Funding Program:
Private Sector – Moment ve Çevre Danışmanlık Müh. Tic.
Completion Date:
24.01.2026
Chemical Synthesis of a Semaglutide Biosimilar for Diabetes Treatment, and Its Development through In Vitro Efficacy, Quality Control, and Characterization Analyses
Ongoing
Principal Investigator:
Project Acceptance Date:
09.04.2025
Project Duration:
12 Months
Funding Program:
Private Sector – Atabay İlaç
Evaluation of the Therapeutic Potential of XNA/DNA Antisense Oligonucleotides That Increase SMN2 Gene Expression in the Treatment of Spinal Muscular Atrophy (SMA), and Their In Vitro Efficacy and Quality Control Characterization Analyses.
Ongoing
Principal Investigator:
Project Acceptance Date:
09.04.2025
Project Duration:
12 Months
Funding Program:
Private Sector – Atabay İlaç
Nanotechnological Approaches Using Graphene Quantum Dots to Enhance the Anticancer Effects of Curcumin and Resveratrol
Ongoing
Principal Investigator:
Project Acceptance Date:
09.04.2025
Project Duration:
12 Months
Funding Program:
Private Sector – Atabay İlaç
Development and Optimization of an In Silico Formulation to Increase the Efficacy of the Nutraceutical Quein Molecule.
Ongoing
Principal Investigator:
Project Acceptance Date:
09.04.2025
Project Duration:
12 Months
Funding Program:
Private Sector – Atabay İlaç
Development of HEK293T Cells Synthesizing Recombinant B-Domain-Deleted rFVIII for Hemophilia A, and Evaluation of Their In Vitro Efficacy and Quality Control Characterization Analyses.
Ongoing
Principal Investigator:
Project Acceptance Date:
09.04.2025
Project Duration:
12 Months
Funding Program:
Private Sector – Atabay İlaç
Determination by HPLC of the Phenolic Composition and Triterpene Content of Standard Extracts Prepared by Soxhlet Extraction from Lavandula stoechas L. (Spanish Lavender), Grown in the Flora of Turkey
Ongoing
Principal Investigator:
Project Acceptance Date:
09.04.2025
Project Duration:
12 Months
Funding Program:
Private Sector – Atabay İlaç
Early-Stage Diagnosis of Alzheimer's Disease with Artificial Intelligence (AI) Using Spatial Data and EEG Data Obtained from VR-Based Cognitive Serious Games
Ongoing
Executing Company:
Iottech Bilişim Danışmanlık Limited Şirketi
Consultants:
Project Acceptance Date:
10.09.2024
Project Duration:
36 Months
Funding Program:
TÜBİTAK - 1501 Industrial R&D Projects Support Program
Development of a Safe Gas Hydrogen Tank Design and Prototype Manufacturing
Completed
Executing Company:
KARBONSAN BASINÇLI KAPLAR SAN. VE TİC. A.Ş.
Consultants:
Project Acceptance Date:
03.11.2023
Project Duration:
24 Months
Funding Program:
TÜBİTAK - 1501 Industrial R&D Projects Support Program
Completion Date:
31.10.2025
MEDGPT (MEDICAL GPT REVOLUTIONIZING HEALTHCARE WITH ETHICAL AI)
Ongoing
Executing Company:
NP İstanbul Hastanesi
Consultants:
Project Acceptance Date:
17.12.2024
Project Duration:
36 Months
Funding Program:
TÜBİTAK-ITEA 4 TEYDEB 1509
SPECTRALHEALTH - APPLICATIONS OF HYPERSPECTRAL IMAGING IN HEALTHCARE
Ongoing
Executing Company:
NP İstanbul Hastanesi
Consultants:
Project Acceptance Date:
25.09.2025
Project Duration:
35 Months
Funding Program:
TÜBİTAK-ITEA 4 TEYDEB 1509
Developing AI ecosystems improving diagnosis and care of mental diseases (DAISY)
Ongoing
Executing Company:
NP İstanbul Hastanesi
Consultants:
Project Acceptance Date:
13.03.2023
Project Duration:
36 Months
Funding Program:
TÜBİTAK-TEYDEB -1509-ITEA 4
Updated DateJuly 29, 2026
Share